Dystroglycan is associated to the disulfide isomerase ERp57

Experimental Cell Research

Volumn 318, Issue 19, 2012, Pages 2460-2469

  Sciandra, Francesca ^a   Angelucci, Emanuela ^a   Altieri, Fabio ^b   Ricci, Daniela ^b   Hübner, Wolfgang ^c   Petrucci, Tamara C ^d   Giardina, Bruno ^a   Brancaccio, Andrea ^a   Bozzi, Manuela ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

DG; DTT; Dystroglycan; ERp57; Fluorescence microscopy; Immunoprecipitation; NEM; Pre DG; Solid phase binding assay; SWGL

Indexed keywords

ALPHA DYSTROGLYCAN; BETA DYSTROGLYCAN; DYSTROGLYCAN; ERP57 PROTEIN; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CELL MEMBRANE; CONFOCAL MICROSCOPY; ENDOPLASMIC RETICULUM; GLYCOSYLATION; HEART; IMMUNOPRECIPITATION; IN VITRO STUDY; KIDNEY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN PROCESSING; RAT; WESTERN BLOTTING; WILD TYPE;

RATTUS;

EID: 84866342604     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.07.006     Document Type: Article

References (36)

1. Winder S.J. The complexities of dystroglycan. Trends Biochem. Sci. 2001, 26:118-124.
2. Barresi R., Campbell K.P. Dystroglycan: from biosynthesis to pathogenesis of human disease. J. Cell. Sci. 2006, 119:199-207.
3. Muntoni F., Torelli S., Brockington M. Muscular dystrophies due to glycosylation defects. Neurotherapeutics 2008, 5:627-632.
4. Ervasti J.M, Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 1993, 122:809-823.
5. Zhang L., Esko J.D. Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. J. Biol. Chem. 1994, 269:19295-19299.
6. Holt K.H., Crosbie R.H., Venzke D.P., Campbell K.P. Biosynthesis of dystroglycan: processing of a precursor propeptide. FEBS Lett. 2000, 468:79-83.
7. Esapa C.T., Bentham G.R., Schroder J.E., Kroger S., Blake D. The effects of posttranslational processing on dystroglycan synthesis and trafficking. FEBS Lett. 2003, 555:209-216.
8. Akhavan A.Please check the journal title, page range, year and volume number in Ref.[8], and correct if necessary., Crivelli S.N., Singh M., Lingappa V.R., Muschler J.L. SEA domain proteolysis determines the functional composition of dystroglycan. FASEB J. 2008, 22:612-621.
9. Bozzi M., Morlacchi S., Bigotti M.G., Sciandra F., Brancaccio A. Functional diversity of dystroglycan. Matrix Biol. 2009, 28:179-187.
10. Bozzi M., Sciandra F., Ferri L., Torreri P., Pavoni E., Petrucci T.C., Giardina B., Brancaccio A. Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro. FEBS J. 2006, 273:4929-4943.
11. Sciandra F., Bozzi M., Morlacchi S., Galtieri A., Giardina B., Brancaccio A. Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor. FEBS J. 2009, 276:4933-4945.
12. Watanabe N., Sasaoka T., Noguchi S., Nishino I., Tanaka T. Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit association. Genes Cells 2007, 12:75-88.
13. Oliver J.D., van der Wal F.J., Bulleid N.J., High S. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 1997, 275:86-88.
14. Jessop C.E., Chakravarthi S., Garbi N., Hämmerling G.J., Lovell S., Bulleid N.J. ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J. 2007, 26:28-40.
15. Turano C., Gaucci E., Grillo C., Chichiarelli S. ERp57/GRP58: a protein with multiple functions. Cell. Mol. Biol. Lett. 2011, 16:539-563.
16. Ndubuisi M.I., Guo G.G., Fried V.A., Etlinger J.D., Sehgal P.B. Cellular physiology of STAT3: where's the cytoplasmic monomer?. J. Biol. Chem. 1999, 274:25499-25509.
17. Coppari S., Altieri F., Ferraro A., Chichiarelli S., Eufemi M., Turano C. Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells. J. Cell. Biochem. 2002, 85:325-333.
18. Eufemi M., Coppari S., Altieri F., Grillo C, Ferraro A., Turano C. ERp57 is present in STAT3-DNA complexes. Biochem. Biophys. Res. Commun. 2004, 323:1306-1312.
19. Nemere I., Farach-Carson M.C., Rohe B., Sterling T.M., Norman A.W., Boyan B.D., Safford S.E. Ribozyme knockdown functionally links a 1,25(OH)2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells. Proc. Natl. Acad. Sci. USA 2004, 101:7392-7397.
20. Chichiarelli S., Gaucci E., Ferraro A., Grillo C., Altieri F., Cocchiola R., Arcangeli V., Turano C., Eufemi M. Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line. Arch. Biochem. Biophys. 2010, 494:178-183.
21. Morlacchi S., Sciandra F., Bigotti M.G., Bozzi M., Hubner W., Galtieri A., Giardina B., Brancaccio A., Insertion of a myc-tag within a-dystroglycan domains improves its biochemical and microscopic detection, BMC Biochemistry, Vol 13(1), DOI: 10.1186/1471-2091-13-14, 2012.
22. Grillo C., D'Ambrosio C., Scaloni A., Maceroni M., Merluzzi S., Turano C., Altieri F. Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors. Free Radic. Biol. Med. 2006, 41:1113-1123.
23. Brancaccio A., Jenö P., Engel J. A single disulfide bridge (Cys182-Cys264) is crucial for alpha-dystroglycan N-terminal domain stability. Ann. N. Y. Acad. Sci. 1998, 857:228-231.
24. Jayasinha V., Nguyen H.H., Xia B., Kammesheidt A., Hoyte K., Martin P.T. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice. Neuromuscul. Disord. 2003, 13:365-375.
25. Di Stasio E., Sciandra F., Maras B., Di Tommaso F., Petrucci T.C., Giardina B., Brancaccio A. Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan. Biochem. Biophys. Res. Commun. 1999, 266:274-278.
26. Brancaccio A., Schulthess T., Gesemann M., Engel J. The N-terminal region of alpha-dystroglycan is an autonomous globular domain. Eur. J. Biochem. 1997, 246:166-172.
27. Jessop C.E., Tavender T.J., Watkins R.H., Chambers J.E., Bulleid N.J. Substrate specificity of the oxidoreductase ERp57 is determined primarily by its interaction with calnexin and calreticulin. J. Biol. Chem. 2009, 284:2194-2202.
28. De Rosa M.C., Pirolli D., Bozzi M., Sciandra F., Giardina B., Brancaccio A. A second Ig-like domain identified in dystroglycan by molecular modelling and dynamics. J. Mol. Graph. Model. 2011, 29:1015-1024.
29. Sevier C.S., Kaiser C.A. Formation and transfer of disulfide bonds in living cells. Nat. Rev. Mol. Cell Biol. 2002, 3:836-847.
30. Walker K.W., Gilbert H.F. Scanning and escape during protein-disulfide isomerase-assisted folding. J. Biol. Chem. 1997, 272:8845-8848.
31. Peaper D.R., Wearsch P.A., Cresswell P. Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J. 2005, 24:3613-3623.
32. Hogg P.J. Disulfide bonds as switches for protein function. Trends Biochem. Sci. 2003, 28:210-214.
33. Jordan P.A., Gibbins J.M. Extracellular disulfide exchange and the regulation of cellular function. Antioxid. Redox Signal. 2006, 8:312-324.
34. Holbrook L-M., Sasikumar P., Stanley R.G., Simmonds A.D., Bicknell A.B., Gibbins J.M. The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function. J. Thromb. Haemost. 2012, 10:278-288.
35. Burgess J.K., Hotchkiss K.A., Suter C., Dudman N.P.B., Szollosi J., Chesterman C.N., Chong B.H., Hogg P.J. Physical proximity and functional association of glycoprotein 1ba and protein disulfide isomerase on the platelet plasma membrane. J. Biol. Chem. 2000, 275:9758-9766.
36. Jordan P.A., Stevens J.M., Hubbard G.P., Barrett N.E., Sage T., Authi K.S., Gibbins J.M. A role for the thiol isomerise protein ERp5 in platelet function. Blood 2005, 105:1500-1507.